DK1183037T3 - Sammensætninger til modulering af immunrespons og til behandling af inflammatoriske sygdomme - Google Patents
Sammensætninger til modulering af immunrespons og til behandling af inflammatoriske sygdommeInfo
- Publication number
- DK1183037T3 DK1183037T3 DK00932513T DK00932513T DK1183037T3 DK 1183037 T3 DK1183037 T3 DK 1183037T3 DK 00932513 T DK00932513 T DK 00932513T DK 00932513 T DK00932513 T DK 00932513T DK 1183037 T3 DK1183037 T3 DK 1183037T3
- Authority
- DK
- Denmark
- Prior art keywords
- compositions
- treating inflammatory
- immune response
- inflammatory diseases
- modulating immune
- Prior art date
Links
- 239000000203 mixture Substances 0.000 title abstract 3
- 208000027866 inflammatory disease Diseases 0.000 title abstract 2
- 230000028993 immune response Effects 0.000 title 1
- FFDGPVCHZBVARC-UHFFFAOYSA-N N,N-dimethylglycine Chemical compound CN(C)CC(O)=O FFDGPVCHZBVARC-UHFFFAOYSA-N 0.000 abstract 2
- 241000237536 Mytilus edulis Species 0.000 abstract 1
- 241001537211 Perna canaliculus Species 0.000 abstract 1
- 230000003110 anti-inflammatory effect Effects 0.000 abstract 1
- 108700003601 dimethylglycine Proteins 0.000 abstract 1
- 230000002519 immonomodulatory effect Effects 0.000 abstract 1
- 210000000987 immune system Anatomy 0.000 abstract 1
- 235000020638 mussel Nutrition 0.000 abstract 1
- 229940078490 n,n-dimethylglycine Drugs 0.000 abstract 1
- 230000002195 synergetic effect Effects 0.000 abstract 1
Classifications
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
- A61K35/00—Medicinal preparations containing materials or reaction products thereof with undetermined constitution
- A61K35/56—Materials from animals other than mammals
- A61K35/618—Molluscs, e.g. fresh-water molluscs, oysters, clams, squids, octopus, cuttlefish, snails or slugs
-
- A—HUMAN NECESSITIES
- A23—FOODS OR FOODSTUFFS; TREATMENT THEREOF, NOT COVERED BY OTHER CLASSES
- A23L—FOODS, FOODSTUFFS, OR NON-ALCOHOLIC BEVERAGES, NOT COVERED BY SUBCLASSES A21D OR A23B-A23J; THEIR PREPARATION OR TREATMENT, e.g. COOKING, MODIFICATION OF NUTRITIVE QUALITIES, PHYSICAL TREATMENT; PRESERVATION OF FOODS OR FOODSTUFFS, IN GENERAL
- A23L33/00—Modifying nutritive qualities of foods; Dietetic products; Preparation or treatment thereof
- A23L33/10—Modifying nutritive qualities of foods; Dietetic products; Preparation or treatment thereof using additives
- A23L33/17—Amino acids, peptides or proteins
- A23L33/175—Amino acids
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
- A61K31/00—Medicinal preparations containing organic active ingredients
- A61K31/185—Acids; Anhydrides, halides or salts thereof, e.g. sulfur acids, imidic, hydrazonic or hydroximic acids
- A61K31/19—Carboxylic acids, e.g. valproic acid
- A61K31/195—Carboxylic acids, e.g. valproic acid having an amino group
- A61K31/197—Carboxylic acids, e.g. valproic acid having an amino group the amino and the carboxyl groups being attached to the same acyclic carbon chain, e.g. gamma-aminobutyric acid [GABA], beta-alanine, epsilon-aminocaproic acid or pantothenic acid
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
- A61P1/00—Drugs for disorders of the alimentary tract or the digestive system
- A61P1/04—Drugs for disorders of the alimentary tract or the digestive system for ulcers, gastritis or reflux esophagitis, e.g. antacids, inhibitors of acid secretion, mucosal protectants
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
- A61P11/00—Drugs for disorders of the respiratory system
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
- A61P11/00—Drugs for disorders of the respiratory system
- A61P11/06—Antiasthmatics
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
- A61P13/00—Drugs for disorders of the urinary system
- A61P13/12—Drugs for disorders of the urinary system of the kidneys
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
- A61P17/00—Drugs for dermatological disorders
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
- A61P19/00—Drugs for skeletal disorders
- A61P19/02—Drugs for skeletal disorders for joint disorders, e.g. arthritis, arthrosis
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
- A61P19/00—Drugs for skeletal disorders
- A61P19/06—Antigout agents, e.g. antihyperuricemic or uricosuric agents
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
- A61P21/00—Drugs for disorders of the muscular or neuromuscular system
- A61P21/04—Drugs for disorders of the muscular or neuromuscular system for myasthenia gravis
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
- A61P25/00—Drugs for disorders of the nervous system
- A61P25/28—Drugs for disorders of the nervous system for treating neurodegenerative disorders of the central nervous system, e.g. nootropic agents, cognition enhancers, drugs for treating Alzheimer's disease or other forms of dementia
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
- A61P27/00—Drugs for disorders of the senses
- A61P27/02—Ophthalmic agents
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
- A61P27/00—Drugs for disorders of the senses
- A61P27/16—Otologicals
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
- A61P29/00—Non-central analgesic, antipyretic or antiinflammatory agents, e.g. antirheumatic agents; Non-steroidal antiinflammatory drugs [NSAID]
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
- A61P3/00—Drugs for disorders of the metabolism
- A61P3/08—Drugs for disorders of the metabolism for glucose homeostasis
- A61P3/10—Drugs for disorders of the metabolism for glucose homeostasis for hyperglycaemia, e.g. antidiabetics
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
- A61P31/00—Antiinfectives, i.e. antibiotics, antiseptics, chemotherapeutics
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
- A61P37/00—Drugs for immunological or allergic disorders
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
- A61P37/00—Drugs for immunological or allergic disorders
- A61P37/02—Immunomodulators
- A61P37/06—Immunosuppressants, e.g. drugs for graft rejection
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
- A61P37/00—Drugs for immunological or allergic disorders
- A61P37/08—Antiallergic agents
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
- A61P5/00—Drugs for disorders of the endocrine system
- A61P5/14—Drugs for disorders of the endocrine system of the thyroid hormones, e.g. T3, T4
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
- A61P7/00—Drugs for disorders of the blood or the extracellular fluid
- A61P7/06—Antianaemics
-
- A—HUMAN NECESSITIES
- A23—FOODS OR FOODSTUFFS; TREATMENT THEREOF, NOT COVERED BY OTHER CLASSES
- A23V—INDEXING SCHEME RELATING TO FOODS, FOODSTUFFS OR NON-ALCOHOLIC BEVERAGES AND LACTIC OR PROPIONIC ACID BACTERIA USED IN FOODSTUFFS OR FOOD PREPARATION
- A23V2002/00—Food compositions, function of food ingredients or processes for food or foodstuffs
Landscapes
- Health & Medical Sciences (AREA)
- Life Sciences & Earth Sciences (AREA)
- Chemical & Material Sciences (AREA)
- Public Health (AREA)
- Veterinary Medicine (AREA)
- General Health & Medical Sciences (AREA)
- Animal Behavior & Ethology (AREA)
- Pharmacology & Pharmacy (AREA)
- Medicinal Chemistry (AREA)
- Engineering & Computer Science (AREA)
- Organic Chemistry (AREA)
- General Chemical & Material Sciences (AREA)
- Chemical Kinetics & Catalysis (AREA)
- Bioinformatics & Cheminformatics (AREA)
- Nuclear Medicine, Radiotherapy & Molecular Imaging (AREA)
- Immunology (AREA)
- Diabetes (AREA)
- Pulmonology (AREA)
- Epidemiology (AREA)
- Physical Education & Sports Medicine (AREA)
- Neurology (AREA)
- Rheumatology (AREA)
- Pain & Pain Management (AREA)
- Mycology (AREA)
- Polymers & Plastics (AREA)
- Biomedical Technology (AREA)
- Food Science & Technology (AREA)
- Endocrinology (AREA)
- Neurosurgery (AREA)
- Nutrition Science (AREA)
- Proteomics, Peptides & Aminoacids (AREA)
- Zoology (AREA)
- Marine Sciences & Fisheries (AREA)
- Hematology (AREA)
- Orthopedic Medicine & Surgery (AREA)
- Transplantation (AREA)
- Hospice & Palliative Care (AREA)
- Urology & Nephrology (AREA)
- Ophthalmology & Optometry (AREA)
- Oncology (AREA)
Applications Claiming Priority (2)
| Application Number | Priority Date | Filing Date | Title |
|---|---|---|---|
| US09/316,001 US20020018787A1 (en) | 1999-05-21 | 1999-05-21 | Methods and compositions for modulating immune response and for the treatment of inflammatory disease |
| PCT/US2000/013513 WO2000071140A2 (en) | 1999-05-21 | 2000-05-18 | Methods and compositions for modulating immune response and for the treatment of inflammatory disease |
Publications (1)
| Publication Number | Publication Date |
|---|---|
| DK1183037T3 true DK1183037T3 (da) | 2004-02-02 |
Family
ID=23227031
Family Applications (1)
| Application Number | Title | Priority Date | Filing Date |
|---|---|---|---|
| DK00932513T DK1183037T3 (da) | 1999-05-21 | 2000-05-18 | Sammensætninger til modulering af immunrespons og til behandling af inflammatoriske sygdomme |
Country Status (11)
| Country | Link |
|---|---|
| US (2) | US20020018787A1 (da) |
| EP (1) | EP1183037B1 (da) |
| JP (1) | JP2003500362A (da) |
| AT (1) | ATE251910T1 (da) |
| AU (1) | AU777971B2 (da) |
| CA (1) | CA2381441A1 (da) |
| DE (1) | DE60005947T2 (da) |
| DK (1) | DK1183037T3 (da) |
| ES (1) | ES2208330T3 (da) |
| MX (1) | MXPA01011924A (da) |
| WO (1) | WO2000071140A2 (da) |
Families Citing this family (11)
| Publication number | Priority date | Publication date | Assignee | Title |
|---|---|---|---|---|
| AU2001245453B2 (en) * | 2000-03-14 | 2005-08-25 | National Jewish Medical And Research Center | Method and composition for treating airway hyperresponsiveness |
| EP1603405A4 (en) * | 2003-03-14 | 2006-05-24 | Foodscience Corp | METHOD FOR THE TREATMENT OF CANCER WITH PERNA CANALICULUS INGREDIENTS (EN) AND PERNA CANALICULUS EXTRACTS |
| WO2008035756A1 (fr) * | 2006-09-22 | 2008-03-27 | Heimat Co., Ltd. | Composition anti-angiogénique comportant un extrait ayant une activité anti-angiogénique et une lécithine |
| NZ575985A (en) * | 2009-03-31 | 2010-04-30 | Bomac Research Ltd | Medicament Uptake |
| JP6778219B2 (ja) * | 2015-07-20 | 2020-10-28 | ジャンイン ベンクト アイ サミュエルソン インスティテュート オブ ライフ サイエンス カンパニー リミテッド | 皮膚の炎症を抑制するイガイ接着タンパク質製品及びその適用 |
| WO2017011986A1 (zh) | 2015-07-20 | 2017-01-26 | 赵兵 | 一种空气过滤装置 |
| EP3326640B1 (en) | 2015-07-20 | 2021-08-25 | Jiangyin Bengt I. Samuelsson Institute of Life Science Co., Ltd. | Applications of mussel adhesive protein product in treatment and prevention of diseases related to melanin |
| WO2017028025A1 (zh) | 2015-08-14 | 2017-02-23 | 江阴市本特塞缪森生命科学研究院有限公司 | 贻贝粘蛋白产品及其抑制粘膜炎症的应用 |
| WO2017181371A1 (zh) * | 2016-04-20 | 2017-10-26 | 江阴市本特塞缪森生命科学研究院有限公司 | 贻贝粘蛋白产品及其抑制脏器炎症的应用 |
| US11298395B2 (en) * | 2017-07-24 | 2022-04-12 | Sami Labs Limited | Isolates from spent turmeric for the management of rheumatoid arthritis |
| EP4129313A3 (de) | 2021-08-03 | 2023-05-10 | Theis Theis Cornelsen | Pharmazeutische zusammensetzung zur behandlung von neurodermitis |
Family Cites Families (9)
| Publication number | Priority date | Publication date | Assignee | Title |
|---|---|---|---|---|
| DE2965855D1 (en) * | 1978-09-25 | 1983-08-18 | Farlane Stuart John Mc | Pharmaceutical preparations containing a mollusc extract |
| US4385068A (en) * | 1980-03-10 | 1983-05-24 | Davinci Laboratories, A Division Of Food Science Corporation | N,N-Dimethylglycine and use in immune response |
| US4801453A (en) * | 1984-05-01 | 1989-01-31 | James M. Broadbent | Stabilized mussel extract |
| US4994492A (en) * | 1989-01-09 | 1991-02-19 | Foodscience Corporation | Treatment of melanoma using N,N-dimethylglycine |
| US5118618A (en) * | 1989-10-05 | 1992-06-02 | Foodscience Corporation | Dimethylglycine enhancement of antibody production |
| US5026728A (en) * | 1989-10-05 | 1991-06-25 | Foodscience Corporation | Treatment of arthritis and inflammation using N,N-dimethylglycine |
| AUPM740594A0 (en) * | 1994-08-11 | 1994-09-01 | J.W. Broadbent Nominees Pty. Ltd. | Anti-inflammatory preparation |
| AUPN531195A0 (en) * | 1995-09-11 | 1995-10-05 | J.W. Broadbent Nominees Pty. Ltd. | Lipid extract having anti-inflamatory activity |
| US6255295B1 (en) * | 1996-12-23 | 2001-07-03 | Nutramax Laboratories, Inc. | Aminosugar, glycosaminoglycan or glycosaminoglycan-like compounds, and s-adenosylmethionine composition for the protection, treatment, repair, and reduction of inflammation of connective tissue |
-
1999
- 1999-05-21 US US09/316,001 patent/US20020018787A1/en not_active Abandoned
-
2000
- 2000-05-18 AU AU50223/00A patent/AU777971B2/en not_active Ceased
- 2000-05-18 ES ES00932513T patent/ES2208330T3/es not_active Expired - Lifetime
- 2000-05-18 AT AT00932513T patent/ATE251910T1/de not_active IP Right Cessation
- 2000-05-18 DE DE60005947T patent/DE60005947T2/de not_active Expired - Fee Related
- 2000-05-18 WO PCT/US2000/013513 patent/WO2000071140A2/en active IP Right Grant
- 2000-05-18 DK DK00932513T patent/DK1183037T3/da active
- 2000-05-18 EP EP00932513A patent/EP1183037B1/en not_active Expired - Lifetime
- 2000-05-18 MX MXPA01011924A patent/MXPA01011924A/es active IP Right Grant
- 2000-05-18 JP JP2000619443A patent/JP2003500362A/ja active Pending
- 2000-05-18 CA CA002381441A patent/CA2381441A1/en not_active Abandoned
-
2003
- 2003-03-20 US US10/391,645 patent/US7229646B2/en not_active Expired - Lifetime
Also Published As
| Publication number | Publication date |
|---|---|
| WO2000071140A2 (en) | 2000-11-30 |
| CA2381441A1 (en) | 2000-11-30 |
| MXPA01011924A (es) | 2003-09-04 |
| US20020018787A1 (en) | 2002-02-14 |
| US20030180288A1 (en) | 2003-09-25 |
| US7229646B2 (en) | 2007-06-12 |
| AU777971B2 (en) | 2004-11-04 |
| WO2000071140A3 (en) | 2001-05-31 |
| JP2003500362A (ja) | 2003-01-07 |
| ES2208330T3 (es) | 2004-06-16 |
| EP1183037B1 (en) | 2003-10-15 |
| AU5022300A (en) | 2000-12-12 |
| DE60005947D1 (de) | 2003-11-20 |
| DE60005947T2 (de) | 2004-07-29 |
| EP1183037A2 (en) | 2002-03-06 |
| ATE251910T1 (de) | 2003-11-15 |
Similar Documents
| Publication | Publication Date | Title |
|---|---|---|
| SE9704870D0 (sv) | New pharmaceutical formulation I | |
| DK1129093T3 (da) | Pyrazolopyrimidinonderivater til behandling af impotens | |
| EE9900481A (et) | Väikesed molekulid, mida kasutatakse põletikuliste haiguste raviks | |
| DK1064009T3 (da) | Anvendelse af ekstrakter af irisplanter og Cimicifuga racemosa og tectorigenin som estrogenagtigt organselektivt lægemiddel uden uterotrop virkning | |
| EA200200097A1 (ru) | Имидазоимидазолы и триазолы в качестве противовоспалительных агентов | |
| NO20016007L (no) | Rekombinant anti-CD40-antistoff og anvendelser derav | |
| DK1261601T3 (da) | Substituerede indoler til modulering af NFKB-aktivitet | |
| BG99261A (en) | Steroid glycosides for the treatment of hyperchlesterolemia | |
| DK1183037T3 (da) | Sammensætninger til modulering af immunrespons og til behandling af inflammatoriske sygdomme | |
| DK1299348T3 (da) | Forbindelser og sammensætninger til levering af aktive midler | |
| DK0777482T3 (da) | Kombinationspræparat til behandling af immunsygdomme | |
| DZ3265A1 (fr) | Derives de 4,5-diaryl-3(2h)-furanone comme inhibiteurs de cyclo-oxygenase-2 | |
| BR9811099A (pt) | Inibidores de urocinase | |
| DE69904804T2 (de) | Glucocorticoid selektive entzündungshemmende mittel | |
| NO20013241D0 (no) | Celleadhesjonsinhiberende anti-inflammatoriske og immunundertrykkende forbindelser | |
| DK1053240T3 (da) | Glucocorticoid-selektiv antiinflammatoriske midler | |
| DK1097173T3 (da) | Anvendelse af peptider af IL-2 og derivater deraf som terapeutiske midler | |
| DK0909556T3 (da) | Rosaceae-ekstrakt som bradykininantagonist | |
| WO2004089289A3 (en) | Treating or preventing hot flashes using prodrugs of gaba analogs | |
| MY133125A (en) | Novel dihydroxyhexanoic acid derivatives | |
| DK0956859T3 (da) | Antioxiderende sammensætning til opfangning af frie radikaler, farmaceutisk præparat som omfatter denne samt fremgangsmåde til fremstilling heraf | |
| ATE516027T1 (de) | Orazamid orotat zur vorbeugung von leberschäden | |
| DK0869965T3 (da) | Steroidnitritesterderivater anvendelige som antiinflammatoriske lægemidler | |
| ATE81004T1 (de) | Laktamimide in der behandlung arzneiresistenter protozoeninjektionen. | |
| ATE283256T1 (de) | C-16 ungesätigte fp-selektive prostaglandin analoge |